Since reduced DNA methylation in the AIM2 promoter in CD4+ T cells has been observed in lupus patients,22, 23 we wondered whether DNA methylation‐modulated AIM2 might regulate TFH cell differentiation, which can exert pathogenic effects on SLE. This evidence concerns the gene CD4 and systemic lupus erythematosus.